Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data
作者： Maylene Wong , Lidia Staszewsky , Roberto Latini , Simona Barlera , Robert Glazer
DOI: 10.1016/J.JACC.2003.12.053
关键词:
摘要: AbstractObjectives: The objective of this study was to test the hypothesis that severity left ventricular remodeling predicts response treatment and outcomes in chronic heart failure....
elsevier.com
onlinejacc.org参考文章(25)
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) The Lancet. ,vol. 353, pp. 2001- 2007 ,(1999) , 10.1016/S0140-6736(99)04440-2
F Tristani, R Fletcher, H Loeb, R Smith, R Shabetai, J N Cohn, G R Johnson, T Rector, Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group Circulation. ,vol. 87, pp. 5- 16 ,(1993)
A. T. Hirsch, V. J. Dzau, Tissue Renin-Angiotensin Systems in the Pathophysiology of Heart Failure Springer, Berlin, Heidelberg. pp. 33- 42 ,(1990) , 10.1007/978-3-642-75326-8_5
Miguel A Quiñones, Barry H Greenberg, Helen A Kopelen, Chris Koilpillai, Marian C Limacher, Daniel M Shindler, Brent J Shelton, Debra H Weiner, SOLVD Investigators∗∗, Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy Journal of the American College of Cardiology. ,vol. 35, pp. 1237- 1244 ,(2000) , 10.1016/S0735-1097(00)00511-8
Jay N. Cohn, Gianni Tognoni, Robert D. Glazer, Dirk Spormann, Allen Hester, Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure Journal of Cardiac Failure. ,vol. 5, pp. 155- 160 ,(1999) , 10.1016/S1071-9164(99)90038-6
K T Weber, C G Brilla, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. ,vol. 83, pp. 1849- 1865 ,(1991) , 10.1161/01.CIR.83.6.1849
Raymond John Lipicky, Milton Packer, Role of surrogate end points in the evaluation of drugs for heart failure. Journal of the American College of Cardiology. ,vol. 22, ,(1993) , 10.1016/0735-1097(93)90487-L
J Cohn, Angiotensin receptor blockers and clinical trials in heart failure. European Heart Journal. ,vol. 24, pp. 125- 126 ,(2003) , 10.1016/S0195-668X(02)00628-0
Maylene Wong, Lidia Staszewsky, Alberto Volpi, Roberto Latini, Simona Barlera, Christer Höglund, Quality assessment and quality control of echocardiographic performance in a large multicenter international study: Valsartan in heart failure trial (Val-HeFT). Journal of The American Society of Echocardiography. ,vol. 15, pp. 293- 307 ,(2002) , 10.1067/MJE.2001.115103
Inderjit S. Anand, Maylene Wong, Riberto Latini, Lloyd Fisher, Yann Tong Chiang, Jay N. Cohn, Relation between changes in ejection fraction over time and subsequent mortality and morbidity in Val-HeFT Journal of the American College of Cardiology. ,vol. 41, pp. 218- ,(2003) , 10.1016/S0735-1097(03)81601-7